- FDA comparison of characteristics of hemoglobin-based oxygen carriers could guide development of safe and effective artificial blood products
Posted: 4/30/2018 - Common Ingredients in U.S. Licensed Vaccines
Updated: 4/30/2018 - Complete List of Currently Approved NDA and ANDA Application Submissions (PDF - 26KB)
Posted: 4/30/2018; Updated through 4/30/2018 - Complete List of Currently Approved Premarket Approvals (PMAs) (PDF - 26KB)
Posted: 4/30/2018; Updated through 4/30/2018 - Exceptions and Alternative Procedures Approved Under 21 CFR 640.120 (PDF - 99KB)
Posted: 4/30/2018 - April 27, 2018 Approval Letter - Menactra (PDF - 96KB)
Posted: 4/30/2018
martes, 1 de mayo de 2018
What’s New for Biologics
What’s New for Biologics
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario